These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33561865)

  • 1. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder.
    Colombo G
    Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA
    Holtyn AF; Weerts EM
    Curr Top Behav Neurosci; 2022; 52():157-194. PubMed ID: 32808090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of GABA
    Domi E; Xu L; Toivainen S; Wiskerke J; Coppola A; Holm L; Augier E; Petrella M; Heilig M
    Neuropsychopharmacology; 2023 Aug; 48(9):1386-1395. PubMed ID: 36739350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.
    Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA
    Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
    Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
    Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA
    de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
    Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of medications for alcohol-use disorders targeting the GABAB receptor system.
    Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA
    Logge WB; Morley KC; Haber PS
    Curr Top Behav Neurosci; 2022; 52():195-212. PubMed ID: 33580440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.
    Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L
    Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting GABAB receptors for anti-abuse drug discovery.
    Phillips TJ; Reed C
    Expert Opin Drug Discov; 2014 Nov; 9(11):1307-17. PubMed ID: 25195620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.
    Li X; Risbrough VB; Cates-Gatto C; Kaczanowska K; Finn MG; Roberts AJ; Markou A
    Neuropharmacology; 2013 Jul; 70():156-67. PubMed ID: 23376712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
    Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
    Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA
    Nieto A; Bailey T; Kaczanowska K; McDonald P
    Curr Top Behav Neurosci; 2022; 52():81-118. PubMed ID: 34036555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.
    Kalinichev M; Palea S; Haddouk H; Royer-Urios I; Guilloteau V; Lluel P; Schneider M; Saporito M; Poli S
    Br J Pharmacol; 2014 Feb; 171(4):995-1006. PubMed ID: 24224799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.